Cardlytics (CDLX) EBT (2017 - 2026)

Cardlytics (CDLX) has reported EBT for 10 consecutive years, with -$8.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT fell 42.82% year-over-year to -$8.7 million; the trailing twelve-month figure through Jun 2026 stood at -$103.4 million (up 41.64% YoY), and the FY2025 full-year result was -$103.5 million, up 45.33% from the prior year.
• EBT climbed to -$8.7 million in Q2 2026 per CDLX's latest filing, from -$13.8 million in the prior quarter.
• Across five years, EBT topped out at $33.0 million in Q1 2022 and bottomed at -$378.3 million in Q4 2022.
• Historically, EBT has averaged -$50.6 million across 5 years, with a median of -$14.7 million in 2024.
• The widest YoY moves for EBT: up 232.71% in 2022, down 1820.3% in 2022.
• Over 5 years, EBT stood at -$378.3 million in 2022, then soared by 73.34% to -$100.8 million in 2023, then soared by 84.54% to -$15.6 million in 2024, then jumped by 47.08% to -$8.2 million in 2025, then declined by 4.96% to -$8.7 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$8.7 million, -$13.8 million, and -$8.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.